CHAMPIONS ONCOLOGY, INC. CSBR Cash Flow

Champions oncology, inc. (CSBR)

CashFlow / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11	Jan'11	Oct'10	Jul'10
Operating activities:
Net income
-181	-956	-995	128	-251	42	-320	-1,476	-3,268	-4,601	-5,011	-6,884	-7,033	-8,035	-10,078	-10,445	0	0	0	-8,722	-7,406	-7,180	-7,589	-7,239	-6,330	-6,834	-7,571	-7,947	-8,661	-8,853	-7,544	-5,248	-3,802	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation
575	681	692	636	654	456	515	1,004	1,609	1,709	2,097	2,662	2,410	2,740	2,953	2,599	0	0	0	3,063	2,807	2,410	2,040	2,189	2,376	2,645	2,819	3,048	3,323	4,167	4,634	3,977	3,133	0	0	0
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	652	-965	-1,255	-2,355	-1,821	-74	42	362	525	417	318	252	141	-36	0	0	0
Provision for (recovery of) doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	28	30	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for services
-2	-2	-2	6	23	8	38	30	39	59	29	44	64	59	59	44	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization expense
752	697	670	606	540	497	436	360	294	213	165	168	169	167	164	156	0	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	159	130	105	77	71	61	42	0	0	0
Operating lease right-of use assets
0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for doubtful accounts
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
810	-680	199	531	986	2,123	1,045	1,600	941	672	1,079	986	-82	-6	198	282	0	0	0	-859	825	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Grant receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	504	517	0	0	0
Prepaid expenses and other current assets
57	101	10	21	113	-41	-114	-13	-356	-143	11	-143	127	151	-17	97	0	0	0	200	68	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-597	-1	86	451	1,157	493	0	0	0
Prepaid expenses, deposits and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-133	-71	-275	77	-43	-217	0	0	0
Accounts payable
-214	453	614	653	131	463	378	301	653	398	224	-43	-191	-186	73	482	0	0	0	351	-223	-164	-225	-314	-472	-521	-85	-207	96	-460	-88	389	636	0	0	0
Accrued liabilities
337	500	404	611	302	-23	-159	-90	37	86	329	412	69	19	-196	-102	0	0	0	50	-24	138	-185	-3	-14	223	291	80	323	171	6	-19	62	0	0	0
Operating lease liabilities
0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current liability
-	-	-	-	-	-	-	-	-	-	-	-44	21	50	85	65	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-206	229	735	1,040	1,771	747	1,502	790	1,130	0	0	0	804	977	1,078	754	-58	-71	-484	-694	-1,159	-433	1,130	1,314	1,511	697	0	0	0
Net cash provided by operating activities
612	1,543	1,247	1,862	1,619	854	1,058	-1,226	-837	-1,965	-2,349	-2,840	-3,793	-3,836	-6,304	-6,408	0	0	0	-	-	-	-	-	-	-	-4,490	-5,498	-5,227	-4,262	-2,159	-1,153	-54	0	0	0
Investing activities:
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
834	870	1,372	834	905	773	530	1,229	1,602	1,678	1,659	766	327	308	310	322	0	0	0	227	234	186	105	78	57	183	387	443	519	409	220	160	85	0	0	0
Net cash used in investing activities
-834	-870	-1,372	-834	-902	-770	-527	-1,226	-1,602	-1,678	-1,659	-766	-327	-308	-310	-322	0	0	0	-	-	-	-	-	-	-	-387	-443	-519	-408	-219	-159	-84	0	0	0
Financing activities:
Proceeds from June 2016 Public Offering, net of financing costs of $742
-	-	-	-	-	-	-	-	-	-	-	4,340	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of options and warrants
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Private placement financing, net of financing costs of $880k
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Payment of issuance costs related to March 2015 Private Placement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Finance lease payments
260	236	262	262	59	52	25	25	25	25	25	24	25	25	23	24	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of treasury stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,033	0	0	0
Proceeds from exercise of options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	93	97	117	119	25	21	0	0	0
Net cash provided by financing activities
194	155	1,161	1,203	1,381	1,062	55	13	13	-25	-25	4,316	4,315	4,315	4,317	-42	0	0	0	-	-	-	-	-	-	-	-1	93	97	8,252	8,254	8,118	8,083	0	0	0
Increase in cash
-28	828	1,036	2,231	2,098	1,146	586	-2,439	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash investing activities:
Right-of-use assets obtained in exchange for operating lease liabilities
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in)/provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Exchange rate effect on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-30	-24	-27	-22	-12	25	-31	-42	-37	-54	-41	-20	-55	-60	0	0	0
(Decrease)/Increase in cash and cash equivalents.
-	-	-	-	-	-	-	-	-	-	-	710	195	171	-2,297	-6,772	0	0	0	-4,313	-3,670	-4,995	5,373	4,411	4,807	4,325	-4,920	-5,885	-5,703	3,541	5,856	6,751	7,885	0	0	0
Purchase equipment under finance lease
212	0	-14	235	235	235	249	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-